B-type natriuretic peptides are reliable markers of cardiac strain in CKD pediatric patients

Pediatric Nephrology

Volumn 27, Issue 4, 2012, Pages 617-625

  Rinat, Choni ^a   Becker Cohen, Rachel ^a   Nir, Amiram ^a   Feinstein, Sofia ^a   Algur, Nurit ^b   Ben Shalom, Efrat ^a   Farber, Benjamin ^a   Frishberg, Yaacov ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b SHAARE ZEDEK MEDICAL CENTER   (Israel)

Author keywords

B type natriuretic peptide; Chronic kidney disease; Heart; Pediatric; Troponin

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BRAIN NATRIURETIC PEPTIDE; HEMOGLOBIN; TROPONIN I; TROPONIN T; BIOLOGICAL MARKER; TROPONIN;

ADOLESCENT; ADULT; ARTICLE; CHILD; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC TEST ACCURACY STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE MARKER; ECHOCARDIOGRAPHY; FEMALE; GLOMERULUS FILTRATION RATE; HEART DISEASE; HEART LEFT VENTRICLE MASS; HEART MUSCLE INJURY; HEART STRESS; HEMOGLOBIN BLOOD LEVEL; HUMAN; INFANT; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; RELIABILITY; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; AREA UNDER THE CURVE; BLOOD; CHRONIC KIDNEY FAILURE; CROSS-SECTIONAL STUDY; DOPPLER ECHOCARDIOGRAPHY; HEART; PATHOPHYSIOLOGY; RECEIVER OPERATING CHARACTERISTIC;

ADOLESCENT; AREA UNDER CURVE; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; ECHOCARDIOGRAPHY, DOPPLER; HEART; HEART DISEASES; HUMANS; INFANT; NATRIURETIC PEPTIDE, BRAIN; RENAL INSUFFICIENCY, CHRONIC; ROC CURVE; SENSITIVITY AND SPECIFICITY; TROPONIN; YOUNG ADULT;

EID: 84862271377     PISSN: 0931041X     EISSN: 1432198X     Source Type: Journal    
DOI: 10.1007/s00467-011-2025-4     Document Type: Article

References (27)

1. Zoccali C (2002) Cardiorenal risk as a new frontier of nephrology: Research needs and areas for intervention. Nephrol Dial Transplant 17(Suppl 11):50-54 (Pubitemid 35277066)
2. Greenbaum LA, Warady BA, Furth SL (2009) Current advances in chronic kidney disease in children: Growth, cardiovascular and neurocognitive risk factors. Semin Nephrol 29:425-434
3. Becker-Cohen R, Nir A, Rinat C, Feinstein S, Algur N, Farber B, Frishberg Y (2006) Risk factors for cardiovascular disease in children and young adults after renal transplantation. Clin J Am Soc Nephrol 1:1284-1292
4. Kavey RE, Allada V, Daniels SR, Hayman LL, McCrindle BW, Newburger JW, Parekh RS, Steinberger J, American Heart Association Expert Panel on Population and Prevention Science, American Heart Association Council on Cardiovascular Disease in the Young, American Heart Association Council on Epidemiology and Prevention, American Heart Association Council on Nutrition, Physical Activity and Metabolism, American Heart Association Council on High Blood Pressure Research, AmericanHeart Association Council on Cardiovascular Nursing, American Heart Association Council on the Kidney in Heart Disease, Interdisciplinary Working Group on Quality of Care and Outcomes Research (2006) Cardiovascular risk reduction in high-risk pediatric patients: A scientific statement from the American Heart Association Expert Panel on Population and Prevention Science; the Councils on Cardiovascular Disease in the Young, Epidemiology and Prevention, Nutrition, Physical Activity and Metabolism, High Blood Pressure Research, Cardiovascular Nursing, and the Kidney in Heart Disease; and the Interdisciplinary Working Group on Quality of Care and Outcomes Research: Endorsed by the American Academy of Pediatrics. Circulation 114:2710-2738
5. Schärer K, Schmidt KG, Soergel M (1999) Cardiac structure and function in patients with chronic renal failure. Pediatr Nephrol 13:951-965
6. Lipshultz SE, Somers MJG, Lipsitz SR, Colan SD, Jabs K, Rifai N (2003) Serum cardiac troponin and subclinical cardiac status in pediatric chronic renal failure. Pediatrics 112:79-86 (Pubitemid 36792933)
7. Maisel AS, Krishnaswamy P, Nowak RM, McCord J, Hollander JE, Duc P, Omland T, Storrow AB, Abraham WT, Wu AH, Clopton P, Steg PG, Westheim A, Knudsen CW, Perez A, Kazanegra R, Herrmann HC, McCullough PA, Breathing Not Properly Multinational Study Investigators (2002) Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 347:161-167 (Pubitemid 34764819)
8. Bettencourt P, Azevedo A, Pimenta J, Frioes F, Ferreira S, Ferreira A (2004) N-terminal-pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients. Circulation 110:2168-2174 (Pubitemid 39372496)
9. Madsen LH, Ladefoged S, Corell P, Schou M, Hilderbrandt PR, Atar D (2007) N-terminal pro brain natriuretic peptide predicts mortality in patients with end-stage renal disease in hemodialysis. Kidney Int 71:548-554 (Pubitemid 46398682)
10. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents (2004) The Fourth Report on the Diagnosis, Evaluation, and Treatment of High Blood Pressure in Children and Adolescents. Pediatrics 114:555-576
11. Nir A, Lindinger A, Rauh M, Bar-Oz B, Laer S, Schwachtgen L, Koch A, Falkenberg J, Mir TS (2009) NT-pro-B-type natriuretic peptide in infants and children: Reference values based on combined data from four studies. Pediatr Cardiol 30:3-8
12. Schwartz GJ, Muñoz A, Schneider MF, Mak RH, Kaskel F, Warady BA, Furth SL (2009) New equations to estimate GFR in children with CKD. J Am Soc Nephrol 20:629-637
13. DeSimone G, Daniels SR, Devereux RB, Koren MJ, Meyer RA, Laragh JH (1992) Left ventricular mass and body size in normotensive children and adults: Assessment of allometric relations and impact of overweight. J Am Coll Cardiol 20: 1251-1260
14. Khoury PR, Mitsnefes M, Daniels SR, Kimball TR (2009) Age specific reference intervals for indexed left ventricular mass in children. J Am Soc Echocardiogr 22:709-714
15. Colan SD, Parness IA, Spevak PJ, Sanders SP (1992) Developmental modulation of myocardial mechanics: Age and growth related alterations in afterload and contractility. J Am Coll Cardiol 19:619-629
16. de Simone G, Daniels SR, Kimball TR, Roman MJ, Romano C, Chinali M, Galdeirsi M, Devereux RB (2005) Evaluation of concentric left ventricular geometry in humans: Evidence for age-related systematic underestimation. Hypertension 45:64-68 (Pubitemid 40066415)
17. Rinat C, Becker-Cohen R, Nir A, Feinstein S, Shemesh D, Algur N, Ben Shalom E, Farber B, Frishberg Y (2010) A comprehensive study of cardiovascular risk factors, cardiac function and vascular disease in children with chronic renal failure. Nephrol Dial Transplant 25:785-793
18. Khan N, Hemmelgan BR, Tonelli M, Thompson CR, Levin A (2005) Prognostic value of troponin T and I among asymptomatic patients with end stage renal disease, a meta-analysis. Circulation 112:3088-3096 (Pubitemid 43113440)
19. Schou M, Dalgaard MK, Clemmesen O, Dawson EA, Yoshiga CC, Nielsen HB, Gustafsson F, Hieldebrandt PR, Secher NH (2005) Kidneys extract BNP and NT proBNP in healthy young men. J Appl Phisiol 99:1676-1680 (Pubitemid 41547162)
20. Anwaruddin S, Lloyd-Jones DM, Baggish A, Krauser D, Tung R, Chae C, Januzzi JL Jr (2006) Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement: Results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Study. J Am Coll Cardiol 47:91-97 (Pubitemid 43005170)
21. Koch A, Singer H (2003) Normal values of B type natriuretic psptide in infants, children and adolescents. Heart 89:875-878 (Pubitemid 36920810)
22. Nir A, Bar-Oz B, Perles Z (2004) N terminal natriuretic peptide: Reference plasma levels from birth to adolescence. Elevated levels at birth in infants and children with heart diseases. Acta Pediatr 93:603-607
23. Nybo M, Benn M, Mogelvang R, Jensen JS, Schnohr P, Rehfeld RF, Goetze JP (2007) Impact of hemoglobin on plasma pro-B-type natriuretic peptide concentrations in the general population. Clin Chem 53:1921-1927 (Pubitemid 350036036)
24. Cataliotti A,Malatino LS, JougasakiM(2001) Circulating natriuretic peptide concentrations in patients with end-stage renal disease: Role of brain natriuretic peptide as a biomarker of ventricular remodeling. Mayo Clinic Proc 76:1111-1119 (Pubitemid 33032388)
25. Safley DM, Awad A, Sullivan RA, Sandbserg KR, Mourad I, BoulwareM(2004) Changes in B type natriuretic peptide (BNP) and N-terminal proBNP by hemodialysis. Clin Chem 50:1071-1074
26. Satyan S, Light R, Agarwal R (2007) Relationship of N-terminal pro-B-natriuretic peptide and cardiac troponin T to left ventricular mass and function and mortality in asymptomatic hemodialysis patients. Am J Kidney Dis 50:1009-1019 (Pubitemid 350122814)
27. Bruch C, Fischer C, Sindermann J, Stypmann J, Breithardt G, Gradaus R (2008) Comparison of prognostic usefulness of N-Terminal pro-brain natriuretic peptide in patients with heart failure with versus without chronic kidney disease. Am J Cardiol 102:469-474